Recent studies suggest that royal jelly (RJ) and its related substances may have antiaging properties. However, the molecular mechanisms underlying the beneficial effects remain elusive. We report that the effects of RJ and enzyme-treated RJ (eRJ) on life span and health span in Caenorhabditis elegans (C elegans) are modulated by the sophisticated interplays of DAF-16, SIR-2.1, HCF-1, and 14-3-3 proteins. Dietary supplementation with RJ or eRJ increased C. elegans life span in a dosedependent manner. The RJ and eRJ consumption increased the tolerance of C elegans to oxidative stress, ultraviolet irradiation, and heat shock stress. Our genetic analyses showed that RJ/eRJmediated life-span extension requires insulin/IGF-1 signaling and the activities of DAF-16, SIR-2.1, HCF-1, and FTT-2, a 14-3-3 protein. Earlier studies reported that DAF-16/FOXO, SIR-2.1/SIRT1, FTT-2, and HCF-1 have extensive interplays in worms and mammals. Our present findings suggest that RJ/eRJ-mediated promotion of longevity and stress resistance in C elegans is dependent on these conserved interplays. From an evolutionary point of view, this study not only provides new insights into the molecular mechanisms of RJ's action on health span promotion in C elegans, but also has imperative implications in using RJ/eRJ as nutraceuticals to delay aging and age-related disorders.
eRJ remain elusive (16) . To date, a number of genes and pathways have been identified to modulate life span, and many of these lifespan determinants are evolutionally conserved among diverse species. Owing to the powerful feature that nematode C elegans is a genetically tractable multicellular model organism, it has been used extensively to investigate the mechanisms of aging and aging interventions (17) (18) (19) (20) (21) (22) (23) .
Insulin/IGF-1 signaling (IIS) and the forkhead box O transcription factor (DAF-16/FOXO) are major longevity determinants and highly conserved in organisms ranging from worms, flies, and rodents to humans (24) (25) (26) (27) (28) (29) . In C elegans, DAF-2 functions as the insulin/ IGF-1 receptor and triggers the signaling cascade by association with insulin-like ligands to negatively regulate the activities of DAF-16/ FOXO (25, 28, 30, 31) . Increasing expression of daf-16 or attenuation of IIS can dramatically promote the life span and stress response of C elegans. It was found that DAF-16/FOXO regulates various biological processes and its transcriptional activity is tightly controlled by deciphering and integrating various signals (32, 33) . Recent studies demonstrated that some of DAF-16-associated proteins (transcriptional coregulators) facilitated DAF-16 to fine-tune its target gene expression and ensure proper transcriptional outcomes (34) (35) (36) (37) . Of these, HCF-1 (host cell factor) and SIR-2.1, two DAF-16 cofactors, can physically interact with DAF-16 and modulate its transactivity. Interestingly, it was also found that HCF-1 may interact with SIR-2.1 and 14-3-3 proteins to form a protein complex in cells (34, 36, 38) . These findings together proposed that DAF-16, HCF-1, SIR-2.1, and 14-3-3 proteins coordinate to fine-tune the transcriptional activity of DAF-16 through their sophisticated interplays.
Here, we employed C elegans as an animal model to study the action of RJ/eRJ on healthy aging and its underlying mechanisms. We report that both RJ and eRJ can increase C elegans life span. The RJ/eRJ-mediated prolongevity is accompanied with promoted stress responses against oxidative stress, ultraviolet (UV) irradiation, and heat shock stress. Our genetic analyses suggest that both RJ and eRJ prolong C elegans life span by acting through the insulin signaling cascade and DAF-16. Likewise, the RJ/eRJ-mediated life-span extension also requires the activities of SIR-2.1 and HCF-1, as well as FTT-2, a 14-3-3 protein. These results suggest that the prolongevity effect of RJ or eRJ in C elegans is mediated by sophisticated machinery operated by the interplays of DAF-16, HCF-1, SIR-2.1, and 14-3-3 proteins. Our findings not only elucidate the molecular mechanisms by which RJ/eRJ promotes longevity, but also further confirmed the significance of interplays between DAF-16 and SIR-2.1, HCF-1, and 14-3-3 proteins on health span regulation.
Materials and Methods

Strains and Growth Conditions
All strains were maintained at 20°C on nematode growth medium (NGM) seeded with Escherichia coli OP50 feeding strain. A 100 µL of OP50 was dropped on the center of 60 mm NGM plates, which were allowed to dry overnight before the assays were carried out. Strains used in this study were: N2 (Bristol, wild type), daf-16(mgDf50), sir-2.1(ok434), daf-2(e1370), age-1(hx546), ftt-2(n4426), and hcf-1(ok559). All the strains were obtained from the Caenorhabditis Genetics Center (CGC), University of Minnesota, USA.
Preparation of RJ and eRJ
The RJ and eRJ were kindly provided by Yamada Apiculture Center, Inc., Okayama, Japan. To prepare RJ or eRJ supplemented food, appropriate amount of RJ and eRJ in powder form were suspended into the liquid NGM 1 day before the assay.
Life-Span Assay
All life-span assays were carried out at 25°C. Synchronized populations were obtained by allowing 10-15 hermaphrodites lay eggs for 4 hours at 25°C and then removing the parents. The eggs were allowed to hatch and develop. Approximately thirty L4/young adult worms per plate (NGM plate containing 50 µg/mL FUDR to prevent the growth of progeny) were used for each assay (39, 40) . All the assays were carried out in triplicates and a minimum of three independent trials were performed for all conditions. The dead worms were counted starting the day after transfer and exploding, protruding, bagging, or contaminated worms were censored if applicable. We defined the day when we transferred the L4/young adult worms as day 0 of adult age. All statistical analyses were carried out using SPSS software (IBM SPSS Statistics). Kaplan-Meier life-span analysis was carried out and p values were calculated using the log-rank test. p < .05 was accepted as statistically significant.
Stress Assays
The stress assays were performed as described previously with some modifications (22) . Worms were pretreated with 2 mg/mL RJ or 1 mg/mL eRJ, respectively, for two generations at 25°C on OP50-seeded NGM plates. Worms on regular NGM plates without the RJ/eRJ served as controls. Each assay was carried out in three independent trials, and the data were pooled and analyzed using Student's t test. p < .05 was accepted as statistically significant.
A 5 mM paraquat (Sigma-Aldrich, Corp., St Louis, MO) was selected for oxidative stress assays. The RJ/eRJ-pretreated L4/young adult worms and their controls were transferred onto NGM plates containing 5 mM paraquat, and survival was assessed by daily counting until all worms died.
To assay for the protective effect on UV irradiation, RJ/eRJ pretreated L4/young adult worms and controls were transferred to RJ/ eRJ (2 and 1 mg/mL, respectively) plates and regular NGM plates, respectively, and were irradiated at 0.05 J/cm 2 for 20 seconds. The survival of the worms was monitored at 25 o C. For heat shock assay, RJ/eRJ pretreated L4/young adult stage worms and controls were transferred to RJ/eRJ supplemented (2 and 1 mg/mL, respectively) plates and regular NGM plates, respectively. The plates were incubated at 35°C for 3 hours and then transferred back to 25°C. The survival of worms was monitored daily.
Brood Size and Body Bend Assays
The brood size assay was carried out by counting the offspring of a single worm on an NGM plate supplemented with or without RJ/ eRJ (triplicates). Each L4/young worm was allowed to lay eggs at 25°C for 24 hours and was then transferred to a fresh plate until it ceased to lay eggs. The offspring were counted after they reached L3 or L4 phase. This assay was carried out in three independent trials. The data were pooled and analyzed using Student's t test. p < .05 was accepted as statistically significant.
For the motility assay, worms were pretreated with or without RJ/eRJ (2 and 1 mg/mL, respectively) for two generations on NGM plates at 25°C. Three or four RJ/eRJ pretreated or nontreated L4/ young adult nematodes were placed onto individual NGM plates without OP50. The number of body bends performed in 3 minutes was counted, and then the number of body bends per minute was calculated. This assay was carried out in three independent trials. The data were pooled and analyzed using Student's t test. p < .05 was accepted as statistically significant.
Gene Expression Analysis by Quantitative RT-PCR
The nematodes were grown on NGM plates supplemented with or without RJ/eRJ at 25°C, until they reached the young adult stage, then collected in M9 buffer. RNA was prepared using RNAzol® RT reagent (Molecular Research Center, Inc.) and stored at -80°C. Complementary DNA was prepared by using Invitrogen Superscript first strand synthesis system for RT-PCR (Invitrogen). Quantitative PCR (qPCR) was performed using SsoFast EvaGreen Supermix and the CFX96 real-time PCR detection system according to the manufacturer suggested protocol (Bio-Rad). The qPCR conditions were: 95°C for 3 minutes, followed by 40 cycles of 10 seconds at 95°C and 30 seconds at 60°C. act-1 was used as an internal control to normalize the expression levels of target transcripts. Each qPCR experiment was repeated three times using independent RJ/eRJ treatments and RNA preparations. The data were pooled and analyzed using Student's t test, and p < . 
Results
Supplementation of RJ or eRJ Extends C elegans Life Span in a Dose-Dependent Manner
To determine the prolongevity property of RJ and eRJ, we treated wild-type N2 worms with RJ or eRJ at concentrations ranging from 0 to 5 mg/mL in NGM at 25°C. The RJ at 1, 2, and 3 mg/mL significantly increased mean life span from 12.79 days to 13.52 days, 15.52 days, and 14.39 days, respectively. In contrast, RJ at 0.4 and 5 mg/mL hardly influenced C elegans mean life span ( Figure 1A and Table 1 ). Similarly, eRJ at 1, 2, and 3 mg/mL increased mean life span from 12.79 days to 14.44 days, 14.09 days, and 13.95 days, respectively, whereas eRJ at 0.4 and 5 mg/mL barely affected C elegans mean life span ( Figure 1B and Table 1 ). Overall, these findings indicate that both RJ and eRJ supplementation can extend life span in C elegans in a dosedependent manner. A 2 mg/mL of RJ and 1 mg/mL of eRJ were selected as the optimum concentrations to prolong C elegans life span.
Considering the antimicrobial properties of RJ, we wondered whether RJ/eRJ inhibited the growth of feeding E coli OP50 under our assay conditions, thereby extending C elegans life span via dietary restriction (41) . To test this hypothesis, we cultured OP50 in LB medium with 2 mg/mL of RJ or 1 mg/mL of eRJ. We found that neither RJ nor eRJ at their optimum concentrations inhibits the growth of E coli OP50 at any bacterial growth phases (data not shown). Indeed, RJ and eRJ at these concentrations even slightly promoted the growth of OP50 compared with the control medium. Therefore, it is unlikely that RJ/eRJ prolongs C elegans life span through its antimicrobial effect.
Influence of RJ or eRJ Treatment on Reproductive Capacity and Motility
Given that RJ/eRJ promotes C elegans life span, we investigated whether RJ/eRJ alters the worms' other general physiological indexes. In this regard, we tested brood size as the reproductive parameter and motility of worms to reflect their general fitness after RJ/eRJ treatment. The RJ/eRJ treatment did not affect total offspring quantity as compared to nonsupplemented controls (Table 2 ). For the motility assay, young adult worms pretreated with or without RJ/eRJ for two generations were individually transfered to fresh NGM plates and the body bends per minute were counted (42). The RJ/eRJ did not affect worms' body bend frequency, namely motility, relative to nonsupplemented controls ( Table 2 ). These findings suggest that RJ/eRJ-mediated life span Notes: Life span and standard error are shown in days. The life-span experiments were repeated at least three times with similar results, and the data for representative experiments are shown. The life-span data were analyzed using the log-rank test and p values for each individual experiment are shown.
*Results presented in Figure 1A . † Results presented in Figure 1B . ‡ Results presented in Figure 2A . § Results presented in Figure 2B .
||
Results presented in Figure 2C . ¶ Results presented in Figure 2D .
# Results presented in Figure 3A . **Results presented in Figure 3B . † † Results presented in Figure 3C . ‡ ‡ Results presented in Figure 3D . § § Results presented in Figure 3E .
||||
Results presented in Figure 3F .
extension is not associated with any significant changes in reproductive capacity and motility.
Supplementation of RJ or eRJ Modulates C elegans Life Span Through the IIS Cascade and DAF-16
To understand the molecular mechanisms by which RJ/eRJ prolongs life span, we first examined the correlation between RJ/eRJ and the IIS pathway/DAF-16, the major longevity pathway (24, (27) (28) (29) . We supplied null daf-16(mgDf50) mutant worms with 2 mg/mL RJ or 1 mg/mL eRJ and found that neither RJ nor eRJ increased the life span of the daf-16(mgDf50) mutants (Figure 2A and B, and Table 1 ). These findings suggest that the prolongevity effect of RJ/eRJ requires the activity of DAF-16. Next, we tested DAF-2 and AGE-1, two major components of the IIS pathway. As compared to the genotype matched nonsupplemented controls, supplementation of 2 mg/mL RJ or 1 mg/mL eRJ did not extend the life span of either daf-2(e1370) or age-1(hx546) mutants ( Figure 2C and D, and Table 1 ). These findings suggest that RJ/eRJ acts, at least in part, through the IIS pathway and requires DAF-16 to increase life span in C elegans.
Considering that the IIS pathway regulates life span in C elegans by limiting DAF-16 nuclear localization (27-29), we postulated that RJ/eRJ treatment may affect DAF-16 nuclear localization and transcriptional activities. To this end, we examined subcellular localization of DAF-16 using transgenic worms overexpressing DAF-16::GFP (daf-16(mgDf47;xrls87)), which showed GFP signal in almost all somatic cells (28, 38) . Specifically, the DAF-16::GFP worms were supplemented with RJ/eRJ on NGM plates from the early L1 stage until day 2 adults. Then, the DAF-16::GFP signal in live worms (day 2 adults) was observed under a fluorescent microscope (Nikon AZ100). Surprisingly, we did not observed a significant increase of DAF-16-GFP in the nucleus after treatment of either RJ or eRJ (data not shown). We then measured the mRNA levels of daf-16 and its targets (sod-3, mtl-1, C32H11.4, and F21F3.3) to determine whether RJ/eRJ supplementation might influence the activity of DAF-16 (38, 43, 44) . Relative to nonsupplemented controls, the mRNA level of daf-16 was not changed, whereas the expression of sod-3, mtl-1, C32H11.4, and F21F3.3 were significantly altered in RJ/eRJ-treated worms ( Figure 2E ). Taken together, these findings suggest that RJ/eRJ treatment prolongs C elegans life span dependent on the promoted transcriptional activities of DAF-16, which do not require the robust accumulation of DAF-16 in nuclei.
RJ/eRJ-Mediated Life-Span Extension Is Modulated by SIR-2.1 and HCF-1, as Well as FTT-2 SIR-2.1, functioning as a protein deacetylase, has been implicated in life-span modulation (34, (45) (46) (47) (48) . We therefore examined whether SIR-2.1 is involved in RJ/eRJ-mediated life-span extension. To this end, we measured the life span of sir-2.1(ok434) null mutants treated with 2 mg/mL of RJ or 1mg/mL of eRJ. Both RJ and eRJ supplementation are incapable of extending the life span of sir-2.1(ok434) worms, implying an important role for SIR-2.1 in RJ/ eRJ-mediated life-span extension ( Figure 3A and B, and Table 1 ).
It was reported that SIR-2.1 physically associates with DAF-16 via FTT-2, a 14-3-3 protein, to promote the transactivation of DAF-16 under heat stress (34, 49) . Additionally, genetic and biochemical studies demonstrated that, associated with 14-3-3 proteins, HCF-1 and SIR-2.1/SIRT1 physically interact and antagonize each other to fine-tune target gene expressions of DAF-16/FOXO, then in turn promoting longevity and stress response (36, 38) . Therefore, we further examined whether RJ/eRJ modulates C elegans life span dependent on HCF-1and FTT-2. We measured the life spans of deletion mutant worms ftt-2(n4426) and hcf-1(ok559), treated with RJ or eRJ. Both ftt-2(n4426) and hcf-1(ok559) supplemented with RJ/ eRJ show similar life spans as their controls without RJ/eRJ supplementation ( Figure 3C -F, and Table 1 ), suggesting that HCF-1 and FTT-2 are required in RJ/eRJ-mediated prolongevity.
Considering that either overexpression of SIRT-2.1 or attenuation of HCF-1 can extend C elegans life span (38,45), we wondered whether RJ/eRJ supplementation extended life span by altering the expression of SIR-2.1 and HCF-1. To address this concern, we employed qPCR to measure the expression levels of sir-2.1 and hcf-1 with or without RJ/eRJ supplementation and found that mRNA levels of both sir-2.1 and hcf-1 were not significantly altered compared with controls ( Figure 2E ). As earlier studies revealed that SIR-2.1, HCF-1, and 14-3-3 may collaborate to fine-tune DAF-16 transactivity in C elegans and the interplays of DAF-16/FOXOs, SIR-2.1/ SIRT1, and HCF-1 are evolutionarily conserved in mammals, our findings together suggest that RJ/eRJ modulates life span dependent, at least in part, on the sophisticated interplays of DAF-16, SIR-2.1, HCF-1, and 14-3-3 proteins.
Supplementation of RJ or eRJ Promotes C elegans Stress Response to Oxidative, UV Irradiation, and Heat Shock Stresses
Elevated stress resistance and life-span extension are generally linked (50) (51) (52) (53) . To test whether RJ/eRJ consumption might also enhance C elegans stress response, we exposed worms to several routine environmental stressors, that is, oxidative stress, UV irradiation, and heat shock. For the oxidative stress assay, adult wild-type N2 worms pretreated with and without RJ/eRJ were transferred to NGM plates containing 5mM of paraquat, which is commonly used to generate reactive oxygen species and induce oxidative stress in the cell (54, 55) . The survival of worms was monitored and we found that RJ/eRJ supplementation robustly increased C elegans survival under paraquat-induced oxidative stress ( Figure 4A and B) . Next, we determined the response of C elegans to UV irradiation and heat shock. In brief, young adult N2 worms pretreated with or without RJ/eRJ were exposed to 0.05 j/ Table 1 . cm 2 UV irradiation for 20 seconds or 35°C for 3 hours, respectively, followed by survival assays at 25 °C. The RJ/eRJ supplementation significantly prolonged the survival time of worms after exposure to UV irradiation compared with nonsupplemented controls ( Figure 4C and D) . Similarly, wild type C elegans pretreated with RJ/eRJ showed elevated resistance to heat shock relative to RJ/eRJ untreated controls ( Figure 4E and F) . Overall, our findings indicate that both RJ and eRJ supplementations can dramatically improve resistance to acute oxidative stress, UV irradiation, and heat shock in C elegans. The RJ-treated N2 worms (2 mg/mL) exhibited increased survival after 3 hours at 35°C compared with nontreated worms. (F) The eRJ-treated N2 worms (1 mg/ mL) exhibited increased survival after 3 hours at 35°C compared with nontreated worms. Each stress assay was repeated at least three times. "Fraction alive" indicates the average survival among the multireplicates and error bars represent the standard deviation. p value was calculated using Student's t test. *p < .05 compared with corresponding control. Each of the stress assays was repeated at least three independent times with similar results.
Given that the molecular mechanisms behind life span and stress resistance may not overlap (56), we wondered whether these RJ/ eRJ-mediated stress resistances may also require, at least partially, the interplays of DFA-16, SIR-2.1, HCF-1, and 14-3-3 proteins. To address this concern, we observed the survival time of mutant worms of daf-16(mgDf50), sir-2.1(ok434), hcf-1(ok559), and ftt-2(n4426) under oxidative stress, UV irradiation, and heat shock stress. When compared with nontreated controls, RJ/eRJ supplementation did not significantly prolong the survival time of each mutant under paraquat-induced oxidative stress ( Table 3 ), suggesting that all proteins of DAF-16, SIR-2.1, HCF-1, and FTT-2 are involved in RJ/ eRJ-mediated oxidative stress resistance. Interestingly, it is worth noting that the p values of RJ/eRJ treatment versus nontreatment in daf-16(mgDf50) and hcf-1(ok559) are just beyond the statistical significance (p ˂ .05), but very close to it. The data also imply that some other regulators may also be involved in and contribute to the RJ/eRJ-mediated resistance to oxidative stress. Furthermore, our results suggested that RJ/eRJ supplementation requires DAF-16 and SIR-2.1, but not HCF-1 and FTT-2, to protect worms from damage of UV irradiation (Table 3) , whereas all four proteins except HCF-1 are required for RJ/eRJ-mediated improvement in response to heat shock (Table 3) . Overall, our findings suggest that RJ/eRJ may promote stress response of C elegans through, at least in part, modulating the interplays of DAF-16, SIR-2.1, HCF-1, and 14-3-3 proteins.
Discussion
Numerous studies in model organisms have shown that nutraceuticals can provide a variety of health benefits (1,2,22,23,57,58 ). Our present studies suggest that the RJ and its products may be used as potent nutraceuticals to promoting animals' healthy aging. We found that without influencing C elegans' normal physiological traits, both RJ and eRJ consumption substantially extend life span and elevate resistance to oxidative stress, UV irradiation, and heat shock in C elegans. These beneficial effects require the activity of DAF-16 and functional IIS pathway. Intriguingly, supplementation with RJ/eRJ promotes transcriptional activities of DAF-16 but does not significantly increase its nuclear localization. Meanwhile, we found that RJ/eRJ-mediated life span extension also requires SIR-2.1, HCF-1, and FTT-2, all of which were reported to coordinately modulate DAF-16 transactivity (34, 36, 38) . Overall, our findings reveal that RJ/ eRJ supplementation triggers a sophisticated regulatory mechanism, Notes: The life span and standard error are shown in days. The life-span experiments were repeated at least three times with similar results, and the data for representative experiments are shown. The life-span data were analyzed using the log-rank test and p values for each individual experiment are shown. mediated by the interplays of DAF-16, SIR-2.1, HCF-1, and 14-3-3, to fine-tune DAF-16 activities and thereby promote prolongevity and stress responses in C elegans.
Given that about 50% of the dry mass of RJ is proteins, the bioactivities of RJ may largely depend on a variety of proteins (13) . It is conceivable that RJ proteins compose a balanced system selected by nature to determine honeybee's fate/life span and this prolongevity benefit may extend to other animals through food intake of RJ. Our experiments demonstrate that both RJ and eRJ increase C elegans life span, but the optimum application concentrations of RJ and eRJ are different (2 mg/mL for RJ and 1 mg/mL for eRJ) ( Figure 1A and B, Table 1 ). The difference raised an interesting speculation, that is, the unique enzymatic digestion broke the natural balance by altering the bioactivity and cytotoxicity of some RJ proteins, and in turn, the optimized concentration of eRJ for prolongevity is reduced down to 1 mg/mL. In addition, it is known that many of natural substances used for therapeutic benefit have the potential to have their benefits eclipsed by toxic effects at high doses (19, 22, 59) . Consistent with this, we found that 5 mg/mL supplementation of either RJ or eRJ, higher than their optimum concentrations, did not show any prolongevity effect.
FOXO1, the mammalian counterpart of DAF-16, has been reported to play a key role in regulating energy metabolism and maintaining the whole body energy homeostasis (60, 61) . Particular pathologies, such as metabolic dysfunction and insulin resistance, lead to hyperglycemia and glucose intolerance due to dysregulation of FOXO1. Considering the conservation of DAF-16 and FOXO1, our finding that DAF-16 is required for RJ/eRJ-mediated life-span extension suggests that RJ/eRJ may modulate metabolic homeostasis to promote longevity and stress resistance in C elegans. This speculation raises an intriguing possibility that RJ/eRJ supplementation can be implemented as prevention means to fight against metabolic dysfunction diseases such as diabetes and obesity. Interestingly, when we were preparing this manuscript, Pourmoradian and colleagues (62) reported that RJ supplementation may be beneficial for type-2 diabetic patients, which positively supports our results and speculation from a clinical perspective.
It is known that attenuation of IIS promotes nuclear translocation of DAF-16 and life-span extension (20) . Our results demonstrate that RJ/eRJ prolongs C elegans life span, at least in part, through IIS pathway ( Figure 2C and D, and Table 1 ). This finding indicated that more DAF-16 proteins should be translocated into nucleus upon RJ/eRJ supplementation. However, we did not observe the apparent DAF-16 nuclear accumulation in worms when supplemented with RJ/eRJ. Considering that many obvious DAF-16 nuclear accumulations are caused by severe stresses or crucial genes alteration, we reason that RJ/eRJ supplementation may only increase nuclear localization of DAF-16 to levels which are similar to normal physiological level, and this moderate increase cannot be easily observed using regular fluorescence microscopy. Indeed, the changes of DAF-16 target genes expression are more sensitive to detect the activity changes of DAF-16. In support of our hypothesis, DAF-16 target genes, such as sod-3 and mtl-1, were significantly upregulated when treated with RJ/eRJ ( Figure 2E ). As an important transcription factor, DAF-16 acts to influence many important biological functions by regulating expression of many genes. Therefore, the regulatory specificity and precision of DAF-16 is critical to ensure certain biological processes. It has been reported that cofactors of DAF-16 play a vital role in fine-tuning the transcriptional activity of DAF-16 (34) (35) (36) (37) (38) . Our results demonstrate that RJ/eRJ-mediated life-span extension requires the activities of SIR-2.1, HCF-1, 14-3-3 proteins, all of which are cofactors of DAF-16. Previous studies revealed physical interactions between these proteins and hypothesized that the interplays between these proteins and DAF-16 may finetune DAF-16 transactivity. Our findings here provide more evidence to support this hypothesis and explicitly reveal the significance of the interplays in diet-based aging intervention. Based on genetic studies, Li and colleagues (38) reported that IIS and hcf-1 likely act independently to regulate DAF-16. Noticeably, their follow-up research suggested that HCF-1 functions as an integral protein to coordinate DAF-16, SIR-2.1, and 14-3-3 in the nucleus to respond to aging and stress, and also demonstrated that, in the face of reduced IIS, SIR-2.1, HCF-1, and 14-3-3 proteins may control DAF-16 activation in the nucleus (36) . Hence, our results implied that RJ/eRJ supplementation may attenuate IIS and, as such, trigger the regulatory interplays of DAF-16, SIR-2.1, HCF-1, and 14-3-3 in the nucleus autonomously.
Notably, our findings indicate that RJ/eRJ supplementation renders promoted resistance to oxidative stress, UV irradiation, and heat shock in C elegans compared with the nonsupplemented controls (Figure 4) . Given the prolongevity effects of RJ/eRJ, these results together imply that RJ/eRJ treatment may significantly promote C elegans healthy aging by increasing their ability to resist environmental stresses. It is known that DAF-16 is a key regulator of stress responses (32, 43, 63) . Interestingly, recent studies have shown that SIR-2.1, HCF-1, and 14-3-3 proteins are extensively involved into a variety of stress responses in association with DAF-16 (34, 36, 38) , implying the extremely important role of the interplays in regulating stress response. Our findings suggest that RJ/eRJ supplementation may finetune the activity of DAF-16 and, therefore, regulate expression of a subset of target genes to improve survival under stresses. In support of this hypothesis, the DAF-16 target genes (sod-3, mtl-1, and F21F3.3) which promote C elegans response to oxidative stress, heavy metals, and heat shock, were upregulated in RJ/eRJ supplemented worms (38, (64) (65) (66) .
Overall, our study highlights the prolongevity and stress resistance properties of RJ/eRJ and reveals the molecular mechanisms by which RJ/eRJ modulates life span and stress response in C elegans. Our study thoroughly analyzed the genetic requirements for RJ/ eRJ-mediated prolongevity effects and systematically investigated the correlation of prolongevity and stress responses under RJ/eRJ supplementation. Because DAF-16/FOXOs, SIR-2.1/SIRT1, HCF-1, and 14-3-3 proteins are evolutionarily conserved from C elegans to mammals, our findings may have immediate implications in utilizing RJ/eRJ as aging-intervention means to prolong health span and combat age-related diseases in higher order organisms, including humans. 
